Press Releases

All Releases
View Summary Myriad Genetics to Report Fiscal 2011 Second Quarter Financial Results on January 27
Jan 10, 2011
PDF 18.9 KB Add to Briefcase
View Summary Myriad Genetics to Present at the 29th Annual J.P. Morgan Healthcare Conference
Dec 22, 2010
PDF 20.9 KB Add to Briefcase
View Summary Myriad Genetics Launches PANEXIA, New Predictive Test for Hereditary Pancreatic and Related Cancers
Dec 20, 2010
PDF 22.6 KB Add to Briefcase
View Summary Newly Published Study Finds High Prevalence of BRCA Mutations in Breast Carcinoma in Situ (CIS)
Dec 14, 2010
PDF 24.9 KB Add to Briefcase
View Summary Myriad Acquires Novel Technology From Melanoma Diagnostics
Dec 8, 2010
PDF 23.1 KB Add to Briefcase
View Summary Myriad Genetics Applauds Major Health Economic Study That Supports Broad Application of Genetic Testing for Hereditary Colon Cancer
Nov 29, 2010
PDF 25.0 KB Add to Briefcase
View Summary Myriad Genetics to Present at The Lazard Capital Markets 7th Annual Healthcare Conference and The Stephens Fall Investment Conference
Nov 4, 2010
PDF 21.0 KB Add to Briefcase
View Summary Myriad Genetics Reports Fiscal 2011 First Quarter Financial Results
Nov 2, 2010
PDF 19.1 KB Add to Briefcase
View Summary Myriad and Abbott Enter Into Cooperative Agreement
Oct 26, 2010
PDF 15.3 KB Add to Briefcase
View Summary Myriad Genetics to Present at Morningstar's 5th Annual Stocks Forum
Oct 21, 2010
PDF 12.9 KB Add to Briefcase
View Summary Myriad Genetics to Present Prostate Cancer Data at the ASCO-NCI-EORTC Annual Meeting on Molecular Markers in Cancer
Oct 14, 2010
PDF 14.2 KB Add to Briefcase
View Summary Myriad Genetics to Report Fiscal 2011 First Quarter Financial Results on November 2
Oct 12, 2010
PDF 12.2 KB Add to Briefcase
View Summary Myriad Genetics' PROLARIS Test Accurately Predicts Survival With Prostate Cancer
Oct 11, 2010
PDF 16.0 KB Add to Briefcase
View Summary Study Reveals High Prevalence of BRCA Mutations in Women With Triple Negative Breast Cancer (TNBC)
Oct 4, 2010
PDF 15.9 KB Add to Briefcase
View Summary Myriad Genetics to Present at the UBS Global Life Sciences Conference and the Fifth Annual JMP Securities Healthcare Conference
Aug 31, 2010
PDF 13.9 KB Add to Briefcase
View Summary Myriad Announces Additional Stock Repurchase Program
Aug 31, 2010
PDF 14.5 KB Add to Briefcase
View Summary Myriad Genetics to Present at the Morgan Stanley Global Healthcare Conference and the Stifel Nicolaus Healthcare Conference
Aug 24, 2010
PDF 13.3 KB Add to Briefcase
View Summary Myriad Genetics Reports Fiscal 2010 Financial Results
Aug 10, 2010
PDF 21.6 KB Add to Briefcase
View Summary Myriad Genetics Establishes Charitable Program to Give Back to Salt Lake Community
Aug 3, 2010
PDF 13.9 KB Add to Briefcase
View Summary Myriad Genetics to Report Fiscal 2010 Fourth Quarter and Year-End Financial Results on August 10
Jul 20, 2010
PDF 12.3 KB Add to Briefcase
Showing 121-140 of 293 Page: 1 ... 3 4 5 6 7 8 9 10 11 ... 15  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase

Stock Quote (NASDAQ:MYGN)

Price:
38.75
Change:
+ 0.64
Open:
38.12
Previous Close:
38.11
Day High:
38.93
Day Low:
36.82
52 Week High:
42.50
52 Week Low:
20.02
Volume:
1,504,400
4:00 PM ET on Apr 15, 2014
Delayed at least 20 minutes.
Provided by eSignal.

Investor Contact

Scott Gleason
(801) 584-1143
sgleason@myriad.com

Media Contact

Ron Rogers
Corporate Communications and Media Relations
(801) 584-3065
rrogers@myriad.com